NOVA1
RNA-binding protein Nova-1
Also known as: NOVA-1, NOVA1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P51513
- Gene
- NOVA1
- Ensembl
- ENSG00000139910
- Chromosome
- 14
- Canonical length
- 507 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli
OverviewNCBI Gene
This gene encodes a neuron-specific RNA-binding protein, a member of the Nova family of paraneoplastic disease antigens, that is recognized and inhibited by paraneoplastic antibodies. These antibodies are found in the sera of patients with paraneoplastic opsoclonus-ataxia, breast cancer, and small cell lung cancer. Alternatively spliced transcripts encoding distinct isoforms have been described. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
507 residues, UniProt reviewed canonical sequence.
>P51513|NOVA1
1 MMAAAPIQQN GTHTGVPIDL DPPDSRKRPL EAPPEAGSTK RTNTGEDGQY FLKVLIPSYA
61 AGSIIGKGGQ TIVQLQKETG ATIKLSKSKD FYPGTTERVC LIQGTVEALN AVHGFIAEKI
121 REMPQNVAKT EPVSILQPQT TVNPDRIKQT LPSSPTTTKS SPSDPMTTSR ANQVKIIVPN
181 STAGLIIGKG GATVKAVMEQ SGAWVQLSQK PDGINLQERV VTVSGEPEQN RKAVELIIQK
241 IQEDPQSGSC LNISYANVTG PVANSNPTGS PYANTAEVLP TAAAAAGLLG HANLAGVAAF
301 PAVLSGFTGN DLVAITSALN TLASYGYNLN TLGLGLSQAA ATGALAAAAA SANPAAAAAN
361 LLATYASEAS ASGSTAGGTA GTFALGSLAA ATAATNGYFG AASPLAASAI LGTEKSTDGS
421 KDVVEIAVPE NLVGAILGKG GKTLVEYQEL TGARIQISKK GEFVPGTRNR KVTITGTPAA
481 TQAAQYLITQ RITYEQGVRA ANPQKVGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NOVA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 64 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 64 nTPM
- hypothalamus: 44 nTPM
- cerebral cortex: 43 nTPM
- spinal cord: 42 nTPM
- midbrain: 33 nTPM
- amygdala: 31 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 2,590 nCPM
- fibro-adipogenic progenitors: 2,157 nCPM
- brain excitatory neurons: 778 nCPM
- corticotrophs: 709 nCPM
- other brain neurons: 686 nCPM
- bergmann glia: 685 nCPM
Immune cell
- NK-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebellum: 165 nTPM
- hypothalamus: 136 nTPM
- midbrain: 96 nTPM
- medulla oblongata: 95 nTPM
- pons: 94 nTPM
- cerebral cortex: 92 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NOVA1.
Disease | AutoantibodyPubMed
Conditions in which antibodies against NOVA1 are reported. Each links to that disease's full target list.
- Breast Neoplasms 16
- Paraneoplastic Syndromes, Nervous System 13
- Urticaria 5
- Adenocarcinoma 3
- Cerebellar Ataxia 3
- Limbic Encephalitis 3
- Lung Neoplasms 3
Showing 7 of 9 — disease pages carrying at least 10 antigens.
ReferencesPubMed · IEDB
Publications for NOVA1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
55 publications
- Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria.
1996 · J Invest Dermatol · RCR 7.5 · 233 citations - Serum IgG autoantibodies directed against the alpha chain of Fc epsilon RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients?
1995 · J Clin Invest · RCR 7.3 · 242 citations - Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria.
1998 · J Allergy Clin Immunol · RCR 2.8 · 88 citations - Immunological and pathological study of anti-Ri-associated encephalopathy.
1994 · Ann Neurol · RCR 2.8 · 98 citations - Neuro-ophthalmology and paraneoplastic syndromes.
2004 · Curr Opin Neurol · RCR 1.7 · 53 citations
Show 20 more of 55 total
- Neuronal uptake of anti-Hu antibody, but not anti-Ri antibody, leads to cell death in brain slice cultures.
2014 · J Neuroinflammation · RCR 1.5 · 45 citations - Anti-Ri antibodies associated with opsoclonus and progressive encephalomyelitis with rigidity.
1994 · Neurology · RCR 1.4 · 36 citations - Anti-Ri paraneoplastic neurological syndrome presenting with bilateral cranial nerve VI palsy and jaw dystonia-a distinctive syndrome within the anti-Ri spectrum? : Case report and literature review.
2024 · Wien Med Wochenschr · RCR 1.4 · 5 citations - Differences and diversity of autoimmune encephalitis in 77 cases from a single tertiary care center.
2019 · BMC Neurol · RCR 1.3 · 24 citations - Anti-Ri-associated paraneoplastic neurologic disorder without opsoclonus in a patient with breast cancer.
1993 · Neurology · RCR 1.3 · 34 citations - Occult Breast Cancer With Anti-Ri Antibody Positivity and Pontine Hot Cross Bun Sign.
2023 · JAMA Neurol · RCR 1.2 · 5 citations - Anti- RI antibody associated progressive supranuclear palsy like presentation in a patient with breast carcinoma.
2020 · J Neuroimmunol · RCR 1.2 · 16 citations - Opsoclonus-myoclonus syndrome associated with anti Kelch-like protein-11 antibodies in a young female patient without cancer.
2021 · J Neuroimmunol · RCR 1.2 · 13 citations - Anti-Ri-associated paraneoplastic opsoclonus-ataxia syndrome in a man with transitional cell carcinoma.
2001 · Cancer · RCR 1 · 32 citations - Treatment of paraneoplastic neurologic disorders.
2010 · Curr Treat Options Neurol · RCR 1 · 31 citations - Anti-Ri-associated paraneoplastic ophthalmoplegia-ataxia syndrome in a woman with breast cancer: a case report and review of the literature.
2020 · J Med Case Rep · RCR 1 · 10 citations - The neuronal nuclear antigen recognized by the human anti-Ri autoantibody is expressed in central but not peripheral nervous system neurons.
1993 · Neurosci Lett · RCR 0.9 · 42 citations - Autoantibodies against Central Nervous System Antigens and the Serum Levels of IL-32 in Patients with Schizophrenia.
2022 · Neuroimmunomodulation · RCR 0.8 · 7 citations - Paraneoplastic cerebellar degeneration in a patient with breast cancer associated with carbonic anhydrase-related protein VIII autoantibodies.
2020 · J Neuroimmunol · RCR 0.8 · 12 citations - Anti-Ri-associated paraneoplastic cerebellar degeneration and breast cancer: an autopsy case study.
2008 · Clin Neurol Neurosurg · RCR 0.7 · 22 citations - Urticaria, angioedema, and autoimmunity.
1997 · Clin Lab Med · RCR 0.6 · 14 citations - Anti-Ri antibody opsoclonus-myoclonus syndrome and breast cancer: a case report and a review of the literature.
2004 · J Surg Oncol · RCR 0.6 · 23 citations - Pearls & Oy-sters: Gait Instability, Jaw Dystonia, and Horizontal Diplopia in a Woman With Anti-Ri Antibodies and Breast Cancer.
2022 · Neurology · RCR 0.6 · 4 citations - Anti-Ri-associated paraneoplastic brainstem cerebellar syndrome with coexisting limbic encephalitis in a patient with mixed large cell neuroendocrine lung carcinoma.
2015 · J Clin Neurosci · RCR 0.6 · 11 citations - Anti-IgE and anti-Fc epsilon RI autoantibodies in clinical allergy.
1996 · Curr Opin Immunol · RCR 0.5 · 22 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.18
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.32
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- mRNA splicing, via spliceosome
- negative regulation of cold-induced thermogenesis
- nervous system development
- regulation of alternative mRNA splicing, via spliceosome
- RNA processing
- RNA splicing
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NOVA1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NOVA1 as an antibody target. Whether an autoantibody or antibody against NOVA1 could matter depends on whether native NOVA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NOVA1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- This gene encodes a neuron-specific RNA-binding protein, a member of the Nova family of paraneoplastic disease antigens, that is recognized and inhibited by paraneoplastic antibodies.
- These antibodies are found in the sera of patients with paraneoplastic opsoclonus-ataxia, breast cancer, and small cell lung cancer.
Loading the interactive Seroatlas protein explorer...